FDA approves Endo generic Plendil

CHADDS FORD, Pa. — The Food and Drug Administration has approved a drug made by Endo Pharmaceuticals for high blood pressure.



Endo announced Wednesday the approval of felodipine extended-release tablets in the 2.5-mg, 5-mg and 10-mg strengths. Endo's generic drugs division, Qualitest Pharmaceuticals, will manufacture and distribute the product.



The drug is a generic version of AstraZeneca's Plendil extended-release tablets. Felodipine had sales of about $84 million during the 12-month period ended in June, according to IMS Health.

Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.